1-2 of 2
Jean-Michel Boulet
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Eatl-001 Trial: Results of a Phase 2 Study of Brentuximab Vedotin and CHP Followed By Consolidation with High-Dose Therapy - Autologous Stem-Cell Transplantation (HDT-ASCT) in the Frontline Treatment of Patients with Enteropathy-Associated T-Cell Lymphoma

David Sibon, Sherine Khater, Julie Bruneau, Chantal Brouzes, Ludovic Lhermitte, Thierry Jo Molina, Guillaume Cartron, Veronique Morel, Georgia Malamut, Adrien Chauchet, Franck Morschhauser, Baptiste Perard, Jean-Michel Boulet, Anne-Cécile Gauchy, Nadine Cerf-Bensussan, Elizabeth A. Macintyre, Vahid Asnafi, Christophe Cellier, Olivier Hermine
Journal: Blood
Blood (2021) 138 (Supplement 1): 136.
https://doi.org/10.1182/blood-2021-153709
Published: 2021
Journal Articles

Phase I/II Study of Escalating Doses of Idarubicin in Combination with Methotrexate, Vindesine and Prednisolone in Patients with Primary Central Nervous System Lymphoma: Results of the GOELAMS LCP99 Multicenter Trial.

Gaelle Olivier, MD, Martine Gardembas, MD, Vincent Delwail, MD, Annie Le Mevel, MD, Martine Escoffre-Barbe, MD, Annie Brion, MD, Jean Michel Boulet, MD, Philippe Solal-Celigny, MD, Pierre Ingrand, MD, Philippe Colombat, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2694.
https://doi.org/10.1182/blood.V114.22.2694.2694
Published: 2009